Observational study on the safety and tolerability of Gadobutrol (Gadovist) among Filipino patients in Magnetic Resonance Imaging
Patients will be recruited from those who will undergo contrast enhanced MRI. Safety and tolerability will be assessed.
- 18 years old and above undergoing contrast enhanced cranial or spinal MRI with Gadobutrol (Gadovist)
- History of hypersensitivity reaction to gadolinium containing contrast material - Hypersensitivity to any of the ingredients of Gadobutrol (Gadovist) - History of hypersensitivity to any other contrast agent - Patients with uncorrected hypokalemia - Pregnant and lactating women - Patients with severe cardiovascular diseases - Patients in whom MRI cannot be performed.
Many Locations, Philippines
E-mail: [email protected]
Phone: Not Available
Observational study on the safety and tolerability of Gadobutrol (Gadovist) among Filipino patients